Sign in

    Shaan Mir

    Research Analyst at Canaccord Genuity

    Shaan Mir is a Research Analyst at Canaccord Genuity, primarily covering consumer staples and the Canadian cannabis sector, with specific coverage of companies such as SNDL Inc., iAnthus Capital Holdings, The Valens Company (VLNS), and Auxly Cannabis Group (TSE:LABS). His performance metrics include a success rate of 14-15% and an average return per recommendation of approximately -40.8% to -47.2%, though he has made some notably profitable calls, such as a 52.7% return on a sell recommendation for SNDL. Mir's analyst career at Canaccord Genuity dates back at least to 2021, with earlier roles noted as Research Associate and investment coverage of earnings calls, but specific previous firms or a longer-term timeline are not available. His professional credentials, including securities licenses or FINRA registration details, are not publicly listed online.

    Shaan Mir's questions to iANTHUS CAPITAL HOLDINGS (ITHUF) leadership

    Shaan Mir's questions to iANTHUS CAPITAL HOLDINGS (ITHUF) leadership • Q1 2019

    Question

    Shaan Mir from Canaccord Genuity asked for clarity on modeling the $8.5 million April pro forma revenue, the expected timing and contribution from adult-use sales in Massachusetts in 2019, and the inflection point for the accelerated pace of dispensary openings.

    Answer

    CFO Julius Kalcevich confirmed that May's performance continued to be strong after a busy April and that the dispensary opening inflection point would be in the second half of the year, driven by Florida. CEO Hadley Ford added that Massachusetts will be a robust market, and the company is prepared with strong wholesale penetration and well-positioned retail locations ready for recreational conversion.

    Ask Fintool Equity Research AI